BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31454283)

  • 1. Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Why Must We Learn About It?
    de Oliveira Sermoud LMC; Romano S; Chveid M; da Silva Amorim GL
    J Glob Oncol; 2019 Aug; 5():1-5. PubMed ID: 31454283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis.
    George EV; Pharm J; Houston C; Al-Quran S; Brian G; Dong H; Hai W; Reeves W; Yang LJ
    Int J Clin Exp Pathol; 2013; 6(8):1631-42. PubMed ID: 23923082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous Regression and Resolution of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Implications for Research, Diagnosis and Clinical Management.
    Fleming D; Stone J; Tansley P
    Aesthetic Plast Surg; 2018 Jun; 42(3):672-678. PubMed ID: 29445921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG).
    Turton P; El-Sharkawi D; Lyburn I; Sharma B; Mahalingam P; Turner SD; MacNeill F; Johnson L; Hamilton S; Burton C; Mercer N
    J Plast Reconstr Aesthet Surg; 2021 Jan; 74(1):13-29. PubMed ID: 33483089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Systematic Review.
    Leberfinger AN; Behar BJ; Williams NC; Rakszawski KL; Potochny JD; Mackay DR; Ravnic DJ
    JAMA Surg; 2017 Dec; 152(12):1161-1168. PubMed ID: 29049466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Implant-associated Anaplastic Large Cell Lymphoma: Review and Multiparametric Imaging Paradigms.
    Sharma B; Jurgensen-Rauch A; Pace E; Attygalle AD; Sharma R; Bommier C; Wotherspoon AC; Sharma S; Iyengar S; El-Sharkawi D
    Radiographics; 2020; 40(3):609-628. PubMed ID: 32302264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis.
    Kadin ME; Morgan J; Xu H; Epstein AL; Sieber D; Hubbard BA; Adams WP; Bacchi CE; Goes JCS; Clemens MW; Medeiros LJ; Miranda RN
    Hum Pathol; 2018 Aug; 78():54-62. PubMed ID: 29689246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants.
    Cardoso MJ; Wyld L; Rubio IT; Leidenius M; Curigliano G; Cutuli B; Marotti L; Biganzoli L
    Breast; 2019 Apr; 44():90-93. PubMed ID: 30703669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
    Oishi N; Miranda RN; Feldman AL
    Aesthet Surg J; 2019 Jan; 39(Suppl_1):S14-S20. PubMed ID: 30715169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma.
    Los-de Vries GT; de Boer M; van Dijk E; Stathi P; Hijmering NJ; Roemer MGM; Mendeville M; Miedema DM; de Boer JP; Rakhorst HA; van Leeuwen FE; van der Hulst RRWJ; Ylstra B; de Jong D
    Blood; 2020 Dec; 136(25):2927-2932. PubMed ID: 33331925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is breast implant-associated anaplastic large cell lymphoma a hazard of breast implant surgery?
    Fitzal F; Turner SD; Kenner L
    Open Biol; 2019 Apr; 9(4):190006. PubMed ID: 30939983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast implant-associated anaplastic large cell lymphoma: A comprehensive review.
    Marra A; Viale G; Pileri SA; Pravettoni G; Viale G; De Lorenzi F; Nolè F; Veronesi P; Curigliano G
    Cancer Treat Rev; 2020 Mar; 84():101963. PubMed ID: 31958739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent.
    Johnson L; O'Donoghue JM; McLean N; Turton P; Khan AA; Turner SD; Lennard A; Collis N; Butterworth M; Gui G; Bristol J; Hurren J; Smith S; Grover K; Spyrou G; Krupa K; Azmy IA; Young IE; Staiano JJ; Khalil H; MacNeill FA
    Eur J Surg Oncol; 2017 Aug; 43(8):1393-1401. PubMed ID: 28596034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zwitterionic polymer on silicone implants inhibits the bacteria-driven pathogenic mechanism and progress of breast implant-associated anaplastic large cell lymphoma.
    Kim J; Kang S; Choi MH; Park S; Nam SH; Park JU; Lee Y
    Acta Biomater; 2023 Nov; 171():378-391. PubMed ID: 37683967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncological Outcomes After Multidisciplinary Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
    O'Connell RL; Sharma B; El-Sharkawi D; Wotherspoon A; Attygalle AD; MacNeill F; Khan AA; Tasoulis MK
    Ann Surg Oncol; 2023 Oct; 30(10):6170-6175. PubMed ID: 37454017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Human Leukocyte Antigen Expression Between Breast Implant-Associated Anaplastic Large Cell Lymphoma Patients and the General Population.
    Tevis SE; Hunt KK; Miranda RN; Lange C; Butler CE; Clemens MW
    Aesthet Surg J; 2019 Sep; 39(10):1065-1070. PubMed ID: 30715139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytological features of breast implant-associated anaplastic large cell lymphoma in pleural effusion.
    D'Alessandris N; Lucatelli P; Tripodi D; Amabile MI; Ascoli V
    Diagn Cytopathol; 2019 Nov; 47(11):1213-1217. PubMed ID: 31348611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological Profile in Portugal of Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Cross-Sectional Study.
    Cunha A; Horta R; Barreiro D
    Acta Med Port; 2021 Aug; 34(9):572-579. PubMed ID: 33512315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG).
    Turton P; El-Sharkawi D; Lyburn I; Sharma B; Mahalingam P; Turner SD; MacNeill F; Johnson L; Hamilton S; Burton C; Mercer N
    Eur J Surg Oncol; 2021 Feb; 47(2):199-210. PubMed ID: 33358076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thirty-six (36) French cases of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): What do we know about their prosthetic histories, and what conclusions may be drawn?].
    Ruffenach L; Bruant-Rodier C; Goldammer F; Ramelli E; Bodin F; Dissaux C
    Ann Chir Plast Esthet; 2019 Aug; 64(4):285-292. PubMed ID: 31331683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.